# Covista Inc.: financial statements, quarterly

CVSA · NYSE · CIK 730464 · [Other](/sectors/other.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/cvsa.md) · [Financials](/companies/cvsa/financials.md) · [Filings](/companies/cvsa/filings.md) · [Insiders](/companies/cvsa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cvsa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [393](/filings/0001558370-25-000544.md) | [413](/filings/0001558370-25-006986.md) | [410 d](/filings/0001104659-26-092044.md) | [417](/filings/0001104659-25-104397.md) | [448](/filings/0001104659-26-007415.md) | [466](/filings/0001104659-26-057163.md) | [457 d](/filings/0001104659-26-092044.md) | [462](/filings/0001104659-26-120213.md) | [503](/filings/0001104659-26-007415.md) | [487](/filings/0001104659-26-057163.md) | [501 d](/filings/0001104659-26-092044.md) | [512](/filings/0001104659-26-120213.md) |
| Cost of revenue | $m | [172](/filings/0001558370-25-000544.md) | [175](/filings/0001558370-25-006986.md) | [183 d](/filings/0001104659-26-092044.md) | [186](/filings/0001104659-25-104397.md) | [187](/filings/0001104659-26-007415.md) | [200](/filings/0001104659-26-057163.md) | [199 d](/filings/0001104659-26-092044.md) | [201](/filings/0001104659-26-120213.md) | [205](/filings/0001104659-26-007415.md) | [211](/filings/0001104659-26-057163.md) | [217 d](/filings/0001104659-26-092044.md) | [221](/filings/0001104659-26-120213.md) |
| Selling, general and administrative | $m | [156](/filings/0001558370-25-000544.md) | [157](/filings/0001558370-25-006986.md) | [155 d](/filings/0001104659-26-092044.md) | [159](/filings/0001104659-25-104397.md) | [157](/filings/0001104659-26-007415.md) | [175](/filings/0001104659-26-057163.md) | [181 d](/filings/0001104659-26-092044.md) | [176](/filings/0001104659-26-120213.md) | [183](/filings/0001104659-26-007415.md) | [184](/filings/0001104659-26-057163.md) | [188 d](/filings/0001104659-26-092044.md) | [193](/filings/0001104659-26-120213.md) |
| Operating income | $m | [58.6](/filings/0001558370-25-000544.md) | [61.7](/filings/0001558370-25-006986.md) | [68.5 d](/filings/0001104659-26-092044.md) | [70.2](/filings/0001104659-25-104397.md) | [104](/filings/0001104659-26-007415.md) | [90.5](/filings/0001104659-26-057163.md) | [76.9 d](/filings/0001104659-26-092044.md) | [85.5](/filings/0001104659-26-120213.md) | [111](/filings/0001104659-26-007415.md) | [91.3](/filings/0001104659-26-057163.md) | [95.4 d](/filings/0001104659-26-092044.md) | [98.0](/filings/0001104659-26-120213.md) |
| Interest expense | $m | [16.7](/filings/0001558370-25-000544.md) | [16.6](/filings/0001558370-25-006986.md) | [14.7 d](/filings/0001104659-26-092044.md) | [14.5](/filings/0001104659-25-104397.md) | [13.9](/filings/0001104659-26-007415.md) | [13.1](/filings/0001104659-26-057163.md) | [10.9 d](/filings/0001104659-26-092044.md) | [11.1](/filings/0001104659-26-120213.md) | [10.9](/filings/0001104659-26-007415.md) | [13.6](/filings/0001104659-26-057163.md) | [9.8 d](/filings/0001104659-26-092044.md) | [9.9](/filings/0001104659-26-120213.md) |
| Income tax | $m | [7.8](/filings/0001558370-25-000544.md) | [10.6](/filings/0001558370-25-006986.md) | [5.1 d](/filings/0001104659-26-092044.md) | [12.2](/filings/0001104659-25-104397.md) | [21.0](/filings/0001104659-26-007415.md) | [18.5](/filings/0001104659-26-057163.md) | [14.1 d](/filings/0001104659-26-092044.md) | [15.8](/filings/0001104659-26-120213.md) | [25.7](/filings/0001104659-26-007415.md) | [20.0](/filings/0001104659-26-057163.md) | [16.2 d](/filings/0001104659-26-092044.md) | [18.0](/filings/0001104659-26-120213.md) |
| Net income | $m | [39.9](/filings/0001558370-25-000544.md) | [36.8](/filings/0001558370-25-006986.md) | [49.4 d](/filings/0001104659-26-092044.md) | [46.2](/filings/0001104659-25-104397.md) | [75.9](/filings/0001104659-26-007415.md) | [60.8](/filings/0001104659-26-057163.md) | [54.2 d](/filings/0001104659-26-092044.md) | [61.8](/filings/0001104659-26-120213.md) | [76.4](/filings/0001104659-26-007415.md) | [41.6](/filings/0001104659-26-057163.md) | [71.7 d](/filings/0001104659-26-092044.md) | [67.4](/filings/0001104659-26-120213.md) |
| Diluted EPS | $ per share | [0.98](/filings/0001558370-25-000544.md) | [0.93](/filings/0001558370-25-006986.md) | not reported | [1.18](/filings/0001104659-25-104397.md) | [1.98](/filings/0001104659-26-007415.md) | [1.59](/filings/0001104659-26-057163.md) | not reported | [1.67](/filings/0001104659-26-120213.md) | [2.11](/filings/0001104659-26-007415.md) | [1.20](/filings/0001104659-26-057163.md) | not reported | [1.95](/filings/0001104659-26-120213.md) |
| Basic EPS | $ per share | [1.00](/filings/0001558370-25-000544.md) | [0.95](/filings/0001558370-25-006986.md) | not reported | [1.22](/filings/0001104659-25-104397.md) | [2.03](/filings/0001104659-26-007415.md) | [1.64](/filings/0001104659-26-057163.md) | not reported | [1.71](/filings/0001104659-26-120213.md) | [2.14](/filings/0001104659-26-007415.md) | [1.21](/filings/0001104659-26-057163.md) | not reported | [1.99](/filings/0001104659-26-120213.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [183](/filings/0001558370-24-000642.md) | [180](/filings/0001558370-24-006552.md) | [219](/filings/0001558370-25-010780.md) | [265](/filings/0001558370-24-013841.md) | [194](/filings/0001558370-25-000544.md) | [219](/filings/0001558370-25-006986.md) | [200](/filings/0001104659-26-092044.md) | [265](/filings/0001104659-25-104397.md) | [56.3](/filings/0001104659-26-007415.md) | [147](/filings/0001104659-26-057163.md) | [406](/filings/0001104659-26-120213.md) | [222](/filings/0001104659-26-120213.md) |
| Current assets | $m | [381](/filings/0001558370-24-011099.md) | [392](/filings/0001558370-24-011099.md) | [418](/filings/0001558370-25-010780.md) | [517](/filings/0001558370-24-013841.md) | [407](/filings/0001558370-25-000544.md) | [450](/filings/0001558370-25-006986.md) | [416](/filings/0001104659-26-092044.md) | [567](/filings/0001104659-25-104397.md) | [303](/filings/0001104659-26-007415.md) | [404](/filings/0001104659-26-057163.md) | [652](/filings/0001104659-26-120213.md) | [553](/filings/0001104659-26-120213.md) |
| Total assets | $m | [2,701](/filings/0001558370-24-000642.md) | [2,715](/filings/0001558370-24-006552.md) | [2,741](/filings/0001558370-25-010780.md) | [2,818](/filings/0001558370-24-013841.md) | [2,723](/filings/0001558370-25-000544.md) | [2,790](/filings/0001558370-25-006986.md) | [2,752](/filings/0001104659-26-092044.md) | [2,867](/filings/0001104659-25-104397.md) | [2,615](/filings/0001104659-26-007415.md) | [2,737](/filings/0001104659-26-057163.md) | [3,013](/filings/0001104659-26-120213.md) | [2,928](/filings/0001104659-26-120213.md) |
| Current liabilities | $m | [399](/filings/0001558370-24-000642.md) | [509](/filings/0001558370-24-006552.md) | [488](/filings/0001558370-25-010780.md) | [551](/filings/0001558370-24-013841.md) | [385](/filings/0001558370-25-000544.md) | [541](/filings/0001558370-25-006986.md) | [508](/filings/0001104659-26-092044.md) | [577](/filings/0001104659-25-104397.md) | [443](/filings/0001104659-26-007415.md) | [580](/filings/0001104659-26-057163.md) | [597](/filings/0001104659-26-120213.md) | [684](/filings/0001104659-26-120213.md) |
| Total liabilities | $m | [1,332](/filings/0001558370-24-000642.md) | [1,394](/filings/0001558370-24-006552.md) | [1,372](/filings/0001558370-25-010780.md) | [1,428](/filings/0001558370-24-013841.md) | [1,284](/filings/0001558370-25-000544.md) | [1,357](/filings/0001558370-25-006986.md) | [1,319](/filings/0001104659-26-092044.md) | [1,410](/filings/0001104659-25-104397.md) | [1,236](/filings/0001104659-26-007415.md) | [1,373](/filings/0001104659-26-057163.md) | [1,567](/filings/0001104659-26-120213.md) | [1,507](/filings/0001104659-26-120213.md) |
| Long-term debt | $m | [696](/filings/0001558370-24-000642.md) | [648](/filings/0001558370-24-006552.md) | [649](/filings/0001558370-25-010780.md) | [649](/filings/0001558370-24-013841.md) | [650](/filings/0001558370-25-000544.md) | [552](/filings/0001558370-25-006986.md) | [553](/filings/0001104659-26-092044.md) | [553](/filings/0001104659-25-104397.md) | [504](/filings/0001104659-26-007415.md) | [496](/filings/0001104659-26-057163.md) | [658](/filings/0001104659-26-120213.md) | [495](/filings/0001104659-26-120213.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001104659-26-092044.md) | not reported | not reported | [3.8](/filings/0001104659-26-057163.md) | [5.1](/filings/0001104659-26-120213.md) | [5.1](/filings/0001104659-26-120213.md) |
| Shareholders' equity | $m | [1,369](/filings/0001558370-25-006986.md) | [1,321](/filings/0001558370-25-006986.md) | [1,369](/filings/0001104659-26-092044.md) | [1,390](/filings/0001104659-26-007415.md) | [1,439](/filings/0001104659-26-057163.md) | [1,433](/filings/0001104659-26-057163.md) | [1,434](/filings/0001104659-26-120213.md) | [1,458](/filings/0001104659-26-120213.md) | [1,379](/filings/0001104659-26-057163.md) | [1,364](/filings/0001104659-26-057163.md) | [1,446](/filings/0001104659-26-120213.md) | [1,422](/filings/0001104659-26-120213.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(13.2) d](/filings/0001558370-25-000544.md) | [154 d](/filings/0001558370-25-006986.md) | [60.3 d](/filings/0001104659-26-092044.md) | [89.3](/filings/0001104659-25-104397.md) | [(19.0) d](/filings/0001104659-26-007415.md) | [208 d](/filings/0001104659-26-057163.md) | [59.7 d](/filings/0001104659-26-092044.md) | [131](/filings/0001104659-26-120213.md) | [29.7 d](/filings/0001104659-26-007415.md) | [186 d](/filings/0001104659-26-057163.md) | [124 d](/filings/0001104659-26-092044.md) | [114](/filings/0001104659-26-120213.md) |
| Capital expenditure | $m | [9.2 d](/filings/0001558370-25-000544.md) | [12.7 d](/filings/0001558370-25-006986.md) | [16.6 d](/filings/0001104659-26-092044.md) | [10.4](/filings/0001104659-25-104397.md) | [10.7 d](/filings/0001104659-26-007415.md) | [10.2 d](/filings/0001104659-26-057163.md) | [19.0 d](/filings/0001104659-26-092044.md) | [16.0](/filings/0001104659-26-120213.md) | [14.6 d](/filings/0001104659-26-007415.md) | [20.2 d](/filings/0001104659-26-057163.md) | [26.8 d](/filings/0001104659-26-092044.md) | [37.6](/filings/0001104659-26-120213.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [70.1 d](/filings/0001558370-25-000544.md) | [89.9 d](/filings/0001558370-25-006986.md) | [11.5 d](/filings/0001104659-26-092044.md) | [33.2](/filings/0001104659-25-104397.md) | [40.9 d](/filings/0001104659-26-007415.md) | [72.4 d](/filings/0001104659-26-057163.md) | [66.7 d](/filings/0001104659-26-092044.md) | [7.6](/filings/0001104659-26-120213.md) | [165 d](/filings/0001104659-26-007415.md) | [67.5 d](/filings/0001104659-26-057163.md) | [0.0 d](/filings/0001104659-26-092044.md) | [81.0](/filings/0001104659-26-120213.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.1](/filings/0001558370-24-000642.md) | [45.8](/filings/0001558370-24-006552.md) | [42.2](/filings/0001558370-24-013841.md) | [40.8](/filings/0001558370-25-000544.md) | [39.6](/filings/0001558370-25-006986.md) | [39.1](/filings/0001104659-25-104397.md) | [38.4](/filings/0001104659-26-007415.md) | [38.2](/filings/0001104659-26-057163.md) | [37.1](/filings/0001104659-26-120213.md) | [36.2](/filings/0001104659-26-007415.md) | [34.8](/filings/0001104659-26-057163.md) | [34.6](/filings/0001104659-26-120213.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,255,241 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001104659-26-120213.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:23 ET. No prices; not investment advice.